End of Pfizer-Allergan Merger Could Save U.S. Taxpayers Billions
The withdrawal by New York-based pharma giant Pfizer of a proposed merger with Irish company Allergan could save U.S. taxpayers billions. If the merger had been completed under the Treasury Department’s old rules, Pfizer could have dodged paying $35 billion in taxes on $150 billion in overseas profits. In 2014, Treasury revised rules to make …
End of Pfizer-Allergan Merger Could Save U.S. Taxpayers Billions Read More »
